(Sharecast News) - Niox Group reported a strong financial performance for 2025 on Tuesday, with revenue and earnings ahead of market expectations, as the medical device group benefited from robust demand across its clinical and research businesses and successfully launched its next-generation Niox PRO device.
The AIM-traded company said in a...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE